DTIL
PRECISION BIOSCIENCES INC
NASDAQ · Healthcare · Biotechnology · US
$7.95
+14.06%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 25.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.29x
- Price / sales
- 4.93x
- Price / cash flow
- -4.29x
Enterprise value
- Enterprise value
- $141.9M
- EV / sales
- 3.15x
- EV / EBITDA
- -2.91x
- EV / EBIT
- -3.92x
- Market cap
- $222.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026